*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1991 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus and should not be redistributed.  Any       *x*
*x*    research using this corpus or based on it should acknowledge     *x*
*x*    that fact, as well as the preliminary nature of the corpus.      *x*
*x*                             (9/9/1991)                             *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*


(  END_OF_TEXT_UNIT)
( (S  
   (SBAR  Since
	  (S (NP emotional reactions
		 (PP in
		     (NP the
			 higher
			 vertebrates)))
	     (X (VP depend
		    (PP on
			(NP individual experience)))
		and
		(X  
		 (AUX are)
		 (VP aroused
		 
		     (PP in
			 (NP man))
		     ,
		     (PP in
			 (NP addition))
		     ,
		     (PP by
			 (NP complex symbols)))))))
   ,
   (S (NP one)
      (AUX would)
      (VP expect
	  (SBAR that
		(S (NP the hypothalamus)
		   (AUX could)
		   (VP be
		       (VP excited
			      
			   (PP from
			       (NP the cortex)))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (PP In
       (NP experiments
	   (PP with
	       (NP topical application
		   (PP of
		       (NP strychnine))
		   (PP on
		       (NP the cerebral cortex))))))
   ,
   (S (NP the transmission
	  (PP of
	      (NP impulses))
	  (PP (PP from
		  (NP the cortex))
	      (PP to
		  (NP the hypothalamus))))
      (AUX was)
      (VP demonstrated
	  )))
  .)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Moreover)
      ,
      (S (NP the responsiveness
	     (PP of
		 (NP the hypothalamus))
	     (PP to
		 (NP nociceptive stimulation)))
	 (AUX is)
	 (VP  (ADVP greatly)
	      increased
	      )
	 (PP under
	     (NP these conditions))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( 
 (S (NP (X (ADJP  (ADVP Even
			more)
		  complex)
	   and
	   (VP  (ADVP obviously)
		(ADVP cortically)
		induced))
	forms
	(PP of
	    (NP  emotional arousal)))
    (AUX could)
    (VP be
	(VP elicited
	     
	    (PP in
		(NP monkey
		    A))
	    (PP on
		(S (NP *) 
		   (VP seeing
		       (NP (NP monkey B)
			   *LRB*
			   but
			   (NEG not)
			   (NP a rabbit)
			   *RRB*)
		       (PP in
			   (NP emotional stress))))))))
 .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP A
       (VP  (ADVP previously)
	    extinguished) (ADJP conditioned)
       reaction)
   (X (X (AUX was)
	 (VP restored
	     
	     (PP in
		 (NP monkey
		     A))))
      and
      (X  
       (AUX was)
       (VP associated
	       
	   (PP with
	       (NP (NP typical signs
		       (PP of
			   (NP emotional excitement)))
		   (VP including
		       (NP sympathetic discharges))))))))
  .) 
(  END_OF_TEXT_UNIT)
( (S
   (NP It
       (SBAR-1 *pseudo-attach*))
   (VP seems
       (S (NP *)
	  (AUX to)
	  (VP follow)))
   (SBAR-1 (SBAR  that
		  (S (ADVP by
			   and
			   large)
		     (S (NP an antagonism)
			(VP exists
			    (PP between
				(NP (NP the paleo)
				    -
				    and
				    (NP the neocortex))))
			(ADVP as
			      far
			      (PP as
				  (S (NP emotional reactivity)
				     (AUX is)
				     (VP concerned
					 )))))))
	   ,
	   and
	   (SBAR that
		 (S (NP the balance
			(PP between
			    (NP the two systems)))
		    (VP determines
			(NP the emotional responsiveness
			    (PP of
				(NP the organism))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (PP In
       (NP addition))
   ,
   (S (S (NP the (ADJP neocortical-hypothalamic) relations)
	 (VP play
	     (NP a great role)
	     (PP in
		 (NP primates))))
      ,
      (PP as
	  (S (NP 
	      (NP Mirsky)
	      's interesting experiment
	      (PP on
		  (NP the
		      ``
		      communication
		      (PP of
			  (NP affect))
		      '')))
	     (VP demonstrates)))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  But
      (PP  (ADVP even)
	   in
	   (NP (NP  (ADJP relatively
			  primitive) laboratory animals)
	       (ADJP such
		     (PP as
			 (NP the rat)))))
      ,
      (S (NP (NP sex activity)
	     (VP  (ADVP closely)
		  identified
		  (PP with
		      (NP (NP the hypothalamus)
			  and
			  (NP the visceral brain)))))
	 (AUX is)
	 (VP enhanced
	  
	     (PP by
		 (NP the neocortex)))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  
 (S (NP MacLean)
    (VP stressed
	(ADVP correctly)
	(NP (NP the importance
		(PP of
		    (NP the visceral brain))
		(PP for
		    (NP preservation
			(PP of
			    (NP (NP the individual)
				and
				(NP the species))))))
	    ,
	    (PP as
		(S  (NP *)  
		    (VP evidenced
			(PP by
			    (NP the influence
				(PP of
				    (NP (NP the limbic brain)
					*LRB*
					(VP including
					    (NP the hypothalamus))
					*RRB*))
				(PP (PP on
					(NP emotions
					    (VP related
						(PP to
						    (NP (NP fight) and (NP flight))))))
				    and
				    (ADVP also)
				    (PP on
					(NP sexual functions)))))))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  
 (S (NP It
	(SBAR-2 *pseudo-attach*))
    (AUX should)
    (VP be
	(VP added))
    (SBAR-2 that
	    (S (PP in
		   (NP man))
	       (S (NP (ADJP neocortical-hypothalamic) interrelations)
		  (ADVP probably)
		  (VP play
		      (NP a role)
		      (PP in
			  (NP the fusion
			      (PP of
				  (NP emotional processes))
			      (PP with
				  (NP (NP those)
				      (VP underlying
					  (NP (NP perception)
					      ,
					      (NP memory)
					      ,
					      (NP imagination)
					      ,
					      and
					      (NP creativity))))))))))))
 .) 
(  END_OF_TEXT_UNIT)
( (S
   (NP Previous experiences)
   (VP are
       (ADVP obviously)
       (PP of
	   (NP great importance
	       (PP for
		   (NP the
		       (ADJP qualitative and quantitative) emotional
		       response))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (S
      (NP (NP The visceral brain)
	  (ADVP as
		well
		(PP as
		    (NP the neocortex))))
      (AUX is)
      (VP known
	     
	  (S (NP *)
	     (AUX to)
	     (VP contribute
		 (PP to
		     (NP memory))))))
     ,
     but
     (S (NP this topic)
	(VP is
	    (PP beyond
		(NP the scope
		    (PP of
			(NP this paper)))))))
  .)
(  END_OF_TEXT_UNIT)
(  (NP (NP 13
	   .)
       (NP (NP Hypothalamic balance)
	   and
	   (NP its significance))))
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
((S  
  (PP After
      (NP this brief discussion
	  (PP of
	      (NP  (ADJP neo
			 -
			 ,
			 paleocortical
			 ,
			 and
			 cortico-hypothalamic)
		   relations))))
  ,
  (S (NP *) 
     (VP let
	 (NP us)
	 (VP return
	     (ADVP once
		   more)
	     (PP to
		 (NP the problem
		     (PP of
			 (NP (NP hypothalamic balance)
			     and
			     (NP its (ADJP physiological and pathological) significance)))))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP Facilitatory processes)
   (VP take
       (NP place)
       (PP between
	   (NP (NP neocortex) and (NP hypothalamus)))
       (PP via
	   (NP (VP (VP ascending)
		   and
		   (VP descending))
	       pathways))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Thus)
      (S  
       (NP (NP (ADJP cortico-fugal) discharges)
	   (VP induced
	       (PP by
		   (NP topical application
		       (PP of
			   (NP strychnine))
		       (PP to
			   (NP a minute area
			       (PP in
				   (NP the neocortex))))))))
       (VP (VP summate
	       (PP with
		   (NP (NP spikes)
		       (ADJP present
			     (PP in
				 (NP the hypothalamus))))))
	   and
	   (VP cause
	       (NP (VP increased)
		   convulsive discharges)))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (PP On
       (NP the other hand))
   ,
   (S (NP the temporary reduction
	  (PP in
	      (NP hypothalamic excitability))
	  (PP through
	      (NP the injection
		  (PP of
		      (NP a barbiturate))
		  (PP into
		      (NP the posterior hypothalamus)))))
      (VP causes
	  (NP a lessening
	      (PP in
		  (NP (NP frequency) and (NP amplitude)))
	      (PP of
		  (NP cortical strychnine spikes))))
      (PP until
	  (S (NP the hypothalamic excitability)
	     (AUX is)
	     (VP restored)))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Apparently)
      ,
      (S (NP a positive feedback)
	 (VP exists
	     (PP between
		 (NP (NP the posterior hypothalamus)
		     and
		     (NP the cerebral cortex))))))
  .)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Consequently)
      ,
      (SBAR if
	    (S (PP for
		   (NP any reason))
	       (S
		(NP the hypothalamic excitability)
		(VP falls
		    (PP below
			(NP the physiological level))))))
      ,
      (S (NP the
	     (VP lessened) (ADJP hypothalamic-cortical)
	     discharges)
	 (VP lead
	     (PP to
		 (NP a (ADJP diminished) state
		     (PP of
			 (NP activity))
		     (PP in
			 (NP the cortex))))
	     (PP with
		 (NP consequent reduction
		     (PP in
			 (NP the (ADJP cortico-fugal) discharges)))))))
  .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Obviously)
      ,
      (S (NP a vicious cycle)
	 (VP develops)))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP This tendency)
   (AUX can)
   (VP be
       (VP broken
	   (PP  either
		(PP by
		    (S (NP *) 
		       (VP restoring
			   (NP hypothalamic excitability)
			   (ADVP directly))))
		or
		(PP via
		    (NP (ADJP cortico-hypothalamic) pathways))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP It)
   (AUX is)
   (VP believed
       (SBAR that
	     (S (S (NP (NP drug therapy) and (NP electroshock))
		   (VP involve
		       (NP the
			   (ADJP former))))
		and
		(X  (NP psychotherapy)
		    (NP the latter mechanism))))))
  .) 
(  END_OF_TEXT_UNIT)
( (S  
   (PP Before
       (S (NP we)
	  (VP comment
	      (ADVP further)
	      (PP on
		  (NP these pathological conditions)))))
   ,
   (S (NP we)
      (AUX should)
      (VP remember
	  (SBAR that
		(S (NP changes
		       (PP in
			   (NP the state
			       (PP of
				   (NP the hypothalamus))))
		       (PP within
			   (NP physiological limits)))
		   (VP distinguish
		       (NP sleep)
		       (PP from
			   (NP wakefulness))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Thus)
      ,
      (S (S (S (NP a low intensity
		   (PP of
		       (NP (ADJP hypothalamic-cortical) discharges)))
	       (VP prevails
		   (PP in
		       (NP sleep))))
	    and
	    (X (NP a
		   high
		   one)
	       (PP during
		   (NP wakefulness))))
	 ,
	 (S  (NP *)  
	     (VP resulting
		 (PP in
		     (NP (NP synchronous
			     EEG potentials
			     (PP in
				 (NP the
				     (ADJP former))))
			 and
			 (NP asynchrony
			     (PP in
				 (NP the latter condition)))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Moreover)
      ,
      (S  
       (NP the dominance
	   (PP in
	       (NP parasympathetic action))
	   *LRB*
	   (PP with
	       (NP reciprocal inhibition
		   (PP of
		       (NP the
			   (ADJP sympathetic)))))
	   *RRB*
	   (PP at
	       (NP the hypothalamic level)))
       (VP (VP induces
	       ,
	       (PP by
		   (NP its peripheral action))
	       ,
	       (NP the autonomic symptoms
		   (PP of
		       (NP sleep))))
	   and
	   (X  ,
	       (PP by
		   (NP its action
		       (PP on
			   (NP the cortex))))
	       ,
	       (NP a lessening
		   (PP in
		       (NP the reactivity
			   (PP of
			       (NP the (ADJP sensory and motor) apparatus
				   (PP of
				       (NP the
					   somatic nervous
					   system)))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (PP With
       (NP the dominance
	   (PP of
	       (NP the sympathetic division
		   (PP of
		       (NP the hypothalamus))))))
   ,
   (S (NP the opposite changes)
      (VP occur)))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (SBAR  Since
	  (S (NP electrical stimulation
		 (PP of
		     (NP the posterior hypothalamus)))
	     (VP produces
		 (NP the effects
		     (PP of
			 (NP wakefulness))))
	     (SBAR while
		   (S (NP stimulation
			  (PP of
			      (NP the anterior hypothalamus)))
		      (VP induces
			  (NP sleep))))))
   ,
   (S (NP it)
      (AUX may)
      (VP be
	  (VP said
	      (SBAR that
		    (S (NP the reactivity
			   (PP of
			       (NP the whole organism)))
		       (AUX is)
		       (VP altered
		      
			   (PP by
			       (NP a change
				   (PP in
				       (NP the autonomic reactivity
					   (PP of
					       (NP the hypothalamus)))))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP Similar effects)
   (AUX can)
   (VP be
       (VP induced
	   (ADVP reflexly)
	   (PP via
	       (NP the baroreceptor reflexes
		   (PP in
		       (NP (NP man) and (NP animals))))))))
  .)
(  END_OF_TEXT_UNIT)
( (SINV 
   (PP Of
       (NP particular importance))
   (VP is)
   (NP the study
       (PP of
	   (NP the actions
	       (PP of
		   (NP drugs))
	       (PP in
		   (NP this respect))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (SBAR Although
	   (S (NP no drugs)
	      (VP act
		  (PP (ADVP exclusively)
		      on
		      (NP (NP the hypothalamus)
			  or
			  (NP a part
			      (PP of
				  (NP it))))))))
     ,
     (S (NP there)
	(VP is
	    (NP sufficient specificity
		(S (NP *)
		   (AUX to)
		   (VP distinguish
		       (NP (NP drugs)
			   (SBAR 
			    (WHNP which)
			    (S (NP T)
			       (VP shift
				   (NP the hypothalamic balance)
				   (PP to
				       (NP the sympathetic side))))))
		       (PP from
			   (NP (NP those)
			       (SBAR 
				(WHNP which)
				(S (NP T)
				   (VP produce
				       (NP a parasympathetic dominance))))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (S
      (NP The
	  (ADJP former))
      (VP comprise
	  (NP (ADJP analeptic and psychoactive) drugs)))
     ,
     (X (NP the
	    (ADJP latter))
	(NP the tranquilizers)))
  .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP Specific differences)
   (VP exist
       (PP in
	   (NP the action
	       (PP of
		   (NP (NP different drugs)
		       (VP belonging
			   (PP to
			       (NP the same group)))))))
       (PP as
	   ,
	   (PP for
	       (NP instance))
	   ,
	   (PP between
	       (NP (NP reserpine) and (NP chlorpromazine))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (ADJP Important
	 (PP as
	     (S (NP these differences)
		(VP are))))
   ,
   (S (NP they)
      (AUX should)
      (NEG not)
      (VP obscure
	  (NP the basic fact
	      (SBAR that
		    (S (S (PP by
			      (S (NP *) 
				 (VP shifting
				     (NP the hypothalamic balance)
				     (ADVP sufficiently)
				     (PP to
					 (NP the parasympathetic side)))))
			  ,
			  (S (NP we)
			     (VP produce
				 (NP depressions))))
		       ,
		       (SBAR whereas
			     (S (NP a shift
				    (PP in
					(NP the opposite direction)))
				(VP causes
				    (NP (NP excitatory effects)
					and
					,
					(ADVP eventually)
					,
					(NP maniclike changes)))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (S
      (NP (NP The emotional states)
	  (VP produced
	      (PP by
		  (NP drugs))))
      (VP influence
	  (NP the cortical potentials)
	  (PP in
	      (NP a characteristic manner))))
     ;
     ;
     (S (S (NP synchrony)
	   (VP prevails
	       (PP in
		   (NP the EEG
		       (PP of
			   (NP the experimental animal)))))
	   (PP after
	       (NP administration
		   (PP of
		       (NP tranquilizers)))))
	,
	but
	(X  
	 (NP asynchrony)
	 (PP after
	     (NP application
		 (PP of
		     (NP (ADJP analeptic and psychoactive) drugs)))))))
  .)
(  END_OF_TEXT_UNIT)
( (S
   (NP The shock therapies)
   (VP act
       (ADVP likewise)
       (PP on
	   (NP the hypothalamic balance))))
  .)
(  END_OF_TEXT_UNIT)
( 
 (S  
  (NP (NP Physiological experiments)
      and
      (NP clinical observations))
  (AUX have)
  (VP shown
      (SBAR that
	    (S (NP these procedures)
	       (VP (VP influence
		       (NP the
			   (VP  (ADVP hypothalamically)
				controlled)
			   hypophyseal secretions))
		   and
		   (VP increase
		       (NP sympathetic discharges)))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP They)
   (VP shift
       (NP the hypothalamic balance)
       (PP to
	   (NP the sympathetic side))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP This)
   (VP explains
       (NP (NP the beneficial effect
	       (PP of
		   (NP electroshock therapy))
	       (PP in
		   (NP certain depressions)))
	   and
	   (NP (NP a shift
		   (PP in
		       (NP the reaction))
		   (PP (PP from
			   (ADJP hypo))
		       -
		       (PP to
			   (NP normal reactivity
			       (PP of
				   (NP the sympathetic system))))))
	       (PP as
		   (S  (NP *)  
		       (VP shown
			   (PP by
			       (NP the Mecholyl test)))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP Some investigators)
   (AUX have)
   (VP found
       (NP a parallelism
	   (PP (PP between
		   (NP (NP (NP remissions) 
			   and 
			   (NP return
			       (PP of
				   (NP the sympathetic reactivity
				       (PP of
					   (NP the hypothalamus))))
			       (PP to
				   (NP the normal level))))
		       (X (PP as
			      (S  (NP *)  
				  (VP indicated
				      (PP by
					  (NP the Mecholyl test))))))))
	       and
	       ,
	       (ADVP conversely)
	       ,
	       (PP between
		   (NP (NP clinical impairment)
		       and
		       (NP (VP increasing)
			   deviation
			   (PP of
			       (NP this test))
			   (PP from
			       (NP the norm)))))))))
  .)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Nevertheless)
      ,
      (S (NP the theory
	     (SBAR that
		   (S (NP the (VP determining) influence
			  (PP of
			      (NP the hypothalamic balance)))
		      (VP has
			  (NP a profound influence
			      (PP on
				  (NP the clinical behavior
				      (PP of
					  (NP neuropsychiatric patients)))))))))
	 (AUX has)
	 (NEG not)
	 (ADVP yet)
	 (VP been
	     (VP tested
		  
		 (PP on
		     (NP an adequate number
			 (PP of
			     (NP patients))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( 
 (S (S (NP  (NP The Mecholyl
		and
		noradrenalin tests)
	    (VP applied
		(PP with
		    (NP certain precautions))))
       (VP are
	   (NP reliable indicators
	       (PP of
		   (NP this
		       central autonomic
		       balance)))))
    ,
    but
    (S (PP for
	   (NP the sake
	       (PP (PP of
		       (S (NP *) 
			  (VP correlating
			      (NP (ADJP autonomic and clinical) states))))
		   ,
		   and
		   (PP of
		       (S (NP *) 
			  (VP studying
			      (NP the effect
				  (PP of
				      (NP certain therapeutic procedures))
				  (PP on
				      (NP 
				       central autonomic
				       reactions)))))))))
       ,
       (S (NP additional tests)
	  (VP seem
	      (S (NP *)
		 (AUX to)
		 (VP be
		     (ADJP desirable)))))))
 .)
(  END_OF_TEXT_UNIT)
(  
 (S (NP It
	(SBAR-3 *pseudo-attach*))
    (AUX was)
    (VP assumed)
    (SBAR-3 that
	    (S (NP (NP the shift
		       (PP in
			   (NP 
			    autonomic hypothalamic
			    balance)))
		   (VP occurring
		       (ADVP spontaneously)
		       (PP in
			   (NP neuropsychiatric patients))
		       (PP from
			   (NP the application
			       (PP of
				   (NP 
				    certain therapeutic
				    procedures))))))
	       (VP follows
		   (NP (NP the pattern)
		       (VP known
			   (PP from
			       (NP the sleep-wakefulness cycle))))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP A change
       (PP in
	   (NP the balance))
       (PP to
	   (NP the parasympathetic side)))
   (VP leads
       (PP in
	   (NP the normal individual))
       (PP (PP to
	       (NP sleep))
	   or
	   ,
	   (PP in
	       (NP special circumstances))
	   ,
	   (PP to
	       (NP (NP cardiovascular collapse) 
		   or 
		   (NP (NP nausea)
		       and
		       (NP vomiting)))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (PP In
	 (NP both
	     conditions))
     (S (S
	 (NP the (ADJP emotional and perceptual) sensitivity)
	 (AUX is)
	 (VP diminished))
	,
	but
	(S (NP (NP no depression)
	       (ADJP-1 *pseudo-attach*))
	   (VP occurs)
	   (ADJP-1 such
		   (PP as
		       (S (S (NP *)  
			     (AUX is)
			     (VP seen
				 (ADVP clinically)))
			  or
			  (S  (NP *) 
			      (AUX may)
			      (VP be
				  (VP produced
	     
				      (PP in
					  (NP normal persons))
				      (PP by
					  (NP drugs)))))))))))
  .)    
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
((S  
  (NP The fundamental differences
      (PP between
	  (NP (ADJP physiological and pathological)
	      states
	      (PP (PP of
		      (NP-5 (ADJP parasympathetic)
			    *pseudo-attach*))
		  *LRB*
		  and
		  (ADVP also)
		  (PP of
		      (NP-5 (ADJP sympathetic)
			    *pseudo-attach*))
		  *RRB*
		  (NP-5 dominance)))))
  (VP remain
      (S (NP *)
	 (AUX to)
	 (VP be
	     (VP elucidated)))))
 .)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Perhaps)
      (S (NP a clue
	     (PP to
		 (NP  these
		      and
		      related
		      problems)))
	 (VP lies
	     (PP in
		 (NP the fact
		     (SBAR that
			   (S 
			    (NP changes
				(PP in
				    (NP the intensity
					(PP of
					    (NP (NP hypothalamic discharges)
						(SBAR  
						 (WHNP which)
						 (S (NP T)
						    (AUX are)
						    (VP associated
		  
							(PP with
							    (NP changes
								(PP in
								    (NP its balance))))))))))))
			    (VP lead
				(ADVP also)
				(PP to
				    (NP qualitative alterations
					(PP in
					    (NP reactivity))))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (S (NP (NP A state
	      (PP of
		  (NP parasympathetic
		      ``
		      tuning
		      ''
		      (PP of
			  (NP the hypothalamus)))))
	  (VP induced
	      (ADVP experimentally)))
      (VP (VP causes
	      (CONJP (NEG not)
		     only)
	      (NP an increase
		  (PP in
		      (NP the parsympathetic reactivity
			  (PP of
			      (NP this structure))
			  (PP to
			      (NP (X (ADJP direct)
				     and
				     (VP (ADVP reflexly)
					 induced))
				  stimuli))))))
	  ,
	  but
	  (VP leads
	      (ADVP also)
	      (PP to
		  (NP an autonomic reversal)))))
   :
   (S (NP (NP a stimulus)
	  (VP acting
	      (ADVP sympathetically)
	      (PP under
		  (NP control conditions))))
      (VP elicits
	  (PP in
	      (NP this state
		  (PP of
		      (NP  tuning))))
	  (NP a parasympathetic response))))
  !
  !)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Furthermore)
      ,
      (S (S (NP (VP conditioned)
		reactions)
	    (AUX are)
	    (VP  (ADVP fundamentally)
		 altered)
	    (SBAR 
	     (WHADVP when)
	     (S (NP the
		    hypothalamic sympathetic
		    reactivity)
		(AUX is)
		(VP augmented
		    (PP beyond
			(NP a critical level))))))
	 ,
	 and
	 (S (NP (NP several types
		    (PP of
			(NP behavioral changes)))
		(ADJP   (ADVP probably)
			related
			(PP to
			    (NP the degree
				(PP of
				    (NP 
				     central autonomic
				     ``
				     tuning
				     ''))))))
	    (AUX are)
	    (VP observed))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (SBAR If
	    (S  ,
		(PP for
		    (NP instance))
		,
		(S (NP  such
			a change)
		   (AUX is)
		   (VP produced
		       (PP by
			   (NP one
			       or
			       a few insulin comas or electroshocks))))))
      ,
      (S (NP (VP  previously
		  inhibited)
	     (VP conditioned) reactions)
	 (VP reappear)))
  .)
(  END_OF_TEXT_UNIT)
( (S  (ADVP However)
      ,
      (SBAR if
	    (S (NP these procedures)
	       (AUX are)
	       (VP applied
		   (ADVP more often))))
      ,
      (S (NP (VP conditioned)
	     emotional responses)
	 (AUX are)
	 (VP  (ADVP temporarily)
	      abolished)))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (PP In
       (NP other studies))
   ,
   (S (NP loss
	  (PP of
	      (NP differentiation))
	  (PP in
	      (NP (VP  previously
		       established)
		  (VP conditioned) reflexes)))
      (VP resulted
	  (PP from
	      (NP (ADJP repeated)
		  (ADJP convulsive)
		  *LRB*
		  metrazol
		  *RRB*
		  treatments)))
      ,
      (VP suggesting
	  (NP a fundamental disturbance
	      (PP in
		  (NP the balance
		      (PP between
			  (NP (ADJP excitatory and inhibitory) cerebral
			      processes))))))))
  .)
(  END_OF_TEXT_UNIT)
(  
 (S (NP It)
    (AUX has)
    (ADVP further)
    (VP been
	(VP shown
	    (SBAR that
		  :
		  (S (S  *LRB*
			 (NP 1)
			 *RRB*
			 (S (NP an experimental neurosis
				(PP in
				    (NP its initial stages)))
			    (AUX is)
			    (VP associated
				(PP with
				    (NP a reversible shift
					(PP in
					    (NP the
						central autonomic
						balance)))))))
		     ;
		     ;
		     (S  *LRB*
			 (NP 2)
			 *RRB*
			 (S (NP (NP drugs)
				(VP altering
				    (NP the hypothalamic balance)))
			    (VP alter
				(NP (ADJP conditioned)
				    reactions))))
		     ;
		     ;
		     (S  *LRB*
			 (NP 3)
			 *RRB*
			 (S (PP in
				(NP a state
				    (PP of
					(NP depression))))
			    ,
			    (S (NP the
				   positive conditioned
				   stimulus)
			       (AUX may)
			       (VP (VP fail
				       (S (NP *)
					  (AUX to)
					  (VP elicit
					      (NP a conditioned reaction))))
				   but
				   (VP cause
				       (NP an increased synchrony)
				       (ADVP instead
					     (PP of
						 (NP the
						     (ADJP excitatory)
						     (VP  (VP desynchronizing)
							  *LRB*
							  (VP alerting)
							  *RRB*)
						     effect
						     (PP on
							 (NP the A[fj])))))))))))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (S
      (NP These)
      (VP are
	  (NP (ADJP (ADJP few)
		    and
		    (ADJP seemingly
			  disjointed))
	      data)))
     ,
     but
     (S (NP they)
	(VP illustrate
	    (NP the important fact
		(SBAR that
		      (S (NP fundamental alterations
			     (PP in
				 (NP conditioned reactions)))
			 (VP occur
			     (PP in
				 (NP a variety
				     (PP of
					 (NP (NP states)
					     (SBAR (WHPP in
							 (WHNP which))
						   (S
						    (NP the hypothalamic balance)
						    (AUX has)
						    (VP been
							(VP altered
							    (PP by
								(NP (NP physiological experimentation)
								    ,
								    (NP pharmacological action)
								    ,
								    or
								    (NP clinical processes))))))))))))))))))
  .) 
(  END_OF_TEXT_UNIT)
(  (NP (NP 14 .)
       (PP On
	   (NP the physiological basis
	       (PP of
		   (NP some form
		       (PP of
			   (NP psychotherapy))))))))
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP The (ADJP foregoing) remarks)
   (VP imply
       (SBAR that
	     (S (NP the hypothalamic balance)
		(VP plays
		    (NP a crucial role)
		    (PP at
			(NP the crossroads
			    (PP between
				(NP (ADJP physiological and pathological) forms
				    (PP of
					(NP emotion)))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  
 (S (SBAR  If
	   (S (NP this)
	      (VP is
		  (NP the case))))
    ,
    (S (NP one)
       (AUX would)
       (VP expect
	   (SBAR (SBAR  (SBAR that)
			(CONJP (NEG not)
			       only)
			(S (NP (NP (NP the various procedures)
				   (VP (ADVP just)
				       mentioned))
			       (SBAR
				(WHNP which)
				(S (NP T)
				   (VP alter
				       (NP the hypothalamic balance)))))
			   (AUX would)
			   (VP influence
			       (NP (NP emotional state) and (NP behavior)))))
		 but
		 (SBAR that
		       (S (NP (NP  emotion)
			      (NP itself))
			  (AUX would)
			  (VP act
			      (ADVP likewise))))))))
 .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (S (NP We)
      (VP pointed
	  (PRT out)
	  (SBAR that
		(S (NP  emotional excitement)
		   (AUX may)
		   (VP lead
		       (PP to
			   (NP (NP psychosomatic disorders)
			       and
			       (NP neurotic symptoms))))
		   ,
		   (PP  (ADVP particularly)
			in
			(NP certain types
			    (PP of
				(NP personality))))))))
   ,
   but
   (S (NP it
	  (SBAR-6 *pseudo-attach*))
      (AUX is)
      (ADVP also)
      (VP known)
      (SBAR-6 that
	      (S (NP (NP the reliving
			 (PP of
			     (NP a strong emotion)))
		     *LRB*
		     ``
		     (NP abreaction)
		     ''
		     *RRB*)
		 (AUX may)
		 (VP cure
		     (NP a battle neurosis))))))
  .)
(  END_OF_TEXT_UNIT)
( (S
   (NP This phenomenon)
   (VP raises
       (NP the question
	   (SBAR whether
		 (S (NP the guidance
			(PP of
			    (NP the emotions))
			(PP for
			    (NP therapeutic ends)))
		    (AUX may)
		    (NEG not)
		    (VP have
			(NP an
			    (ADJP  even
				   wider)
			    application)
			(PP in
			    (NP the area
				(PP of
				    (NP the neuroses))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (S  (NP *)  
	 (VP Being
	     (NP a
		 (ADJP  strictly
			physiological) procedure)))
     ,
     (S (NP one)
	(AUX may)
	(VP expect
	    (PP from
		(NP  such
		     a study))
	    (NP additional information
		(PP on
		    (NP the nature
			(PP of
			    (NP (NP the emotional process)
				(NP itself)))))))))
  .) 
(  END_OF_TEXT_UNIT)
((S (NP 
     (NP Wolpe)
     's experiments
     and
     therapeutic work)
    (VP lie
	(PP in
	    (NP this area))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  
 (S (NP He)
    (VP (VP showed
	    (ADVP convincingly)
	    (SBAR that
		  (S (NP  anxiety)
		     (VP (VP is
			     (NP a
				 (ADJP (ADJP learned)
				       *LRB*
				       (ADJP conditioned)
				       *RRB*)
				 reaction))
			 and
			 (VP is
			     (NP the basis
				 (PP of
				     (NP (ADJP experimental and clinical) neuroses))))))))
	and
	(VP assumed
	    ,
	    (ADVP therefore)
	    ,
	    (SBAR that
		  (S (NP (NP the neuronal changes)
			 (SBAR 
			  (WHNP which)
			  (S (NP T)
			     (VP underlie
				 (NP the neuroses)))))
		     (VP are
			 (ADJP functional and reversible)))))))
 .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP An important observation
       (PP of
	   (NP Pavlov)))
   (VP served
       (PP as
	   (NP a guide post))
       (S (NP *)
	  (AUX to)
	  (VP achieve
	      (NP  
	       such
	       a reversibility)
	      (PP by
		  (NP physiological means))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (PP In
       (NP a conditioning experiment))
   ,
   (S (NP he)
      (VP demonstrated
	  (NP the antagonism
	      (PP between
		  (NP  (NP feeding)
		       and
		       (NP pain)))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP A
       mild electrical
       shock)
   (X (VP served
	  (PP as
	      (NP a conditioned stimulus)))
      and
      (X  
       (AUX was)
       (VP followed
	   (PP by
	       (NP  feeding))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  
 (S (NP The pain)
    (VP (VP became
	    (ADVP thus)
	    (NP the symbol
		(PP for
		    (NP food))))
	and
	(VP elicited
	    (NP (NP salivary secretion)
		*LRB*
		(NP  conditioned
		     reflex)
		*RRB*))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
((S (SBAR  (ADVP Even)
	   (WHADVP when)
	   (S (NP the intensity
		  (PP of
		      (NP the shocks)))
	      (AUX was)
	      (VP increased
		  (ADVP gradually))))
    ,
    (S (NP it)
       (VP failed
	   (S (NP *)
	      (AUX to)
	      (VP evoke
		  (NP any signs
		      (PP of
			  (NP pain))))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  
   (SBAR  Since
	  (S (NP strong nociceptive
		 stimuli)
	     (VP produce
		 (NP (NP an experimental neurosis)
		     (SBAR (WHPP during
				 (WHNP which))
			   (S (NP the animals)
			      (VP fail
				  (S (NP *)
				     (AUX to)
				     (VP eat)))
			      (PP in
				  (NP the experimental situation))))))))
   ,
   (S (NP Wolpe)
      (VP thought
	  (SBAR that
		(S (NP he)
		   (AUX could)
		   (VP utilize
		       (NP the feeding-pain antagonism)
		       (S (NP *)
			  (AUX to)
			  (VP inhibit
			      (NP the neurotic symptoms)
			      (PP through
				  (NP  feeding))))))))))
  .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP Appropriate experiments)
   (VP showed
       (SBAR that
	     (S (NP this)
		(VP is
		    ,
		    (ADVP indeed)
		    ,
		    (ADJP possible))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP He)
   (ADVP then)
   (VP applied
       (NP this principle
	   (PP of
	       (NP reciprocal inhibition)))
       (PP to
	   (NP human neuroses))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP He)
   (VP (VP took
	   (NP advantage)
	   (PP of
	       (NP the antagonism
		   (PP between
		       (NP (NP aggressive assertiveness) and (NP anxiety))))))
       and
       (VP found
	   (NP a
	       (ADJP  relatively
		      rapid) disappearance
	       (PP of
		   (NP anxiety)))
	   (SBAR 
	    (WHADVP when)
	    (S (NP the former attitude)
	       (AUX was)
	       (VP established))))))
  .)
(  END_OF_TEXT_UNIT)
( (S  
   (PP For
       (NP the interpretation
	   (PP of
	       (NP these significant investigations))))
   ,
   (S (NP it)
      (AUX should)
      (VP be
	  (VP remembered
	      (SBAR that
		    (S (NP reciprocal relations)
		       (VP exist
			   (PP in
			       (NP the hypothalamus)))
		       (PP with
			   (NP respect
			       (PP to
				   (NP (NP (ADJP autonomic and somatic) functions)
				       (SBAR 
					(WHNP which)
					(S (NP T)
					   (AUX are)
					   (VP  (ADVP closely)
						associated
						(PP with
						    (NP the emotions)))))))))))))))
  .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP The feeding-pain antagonism)
   (VP seems
       (S (NP *)
	  (AUX to)
	  (VP be
	      (VP based
		  (PP on
		      (NP this reciprocal relation
			  (PP between
			      (NP the
				  (ADJP tropho
					-
					and
					ergotropic) systems)))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (ADVP Furthermore)
      ,
      (S (NP a functional antagonism)
	 (VP exists
	     (PP between
		 (NP (NP an aggressive attitude)
		     and
		     (NP a state
			 (PP of
			     (NP anxiety))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S  (SBAR Although
	    (S (PP in
		   (NP both
		       emotions))
	       (S (NP sympathetic symptoms)
		  (VP are
		      (ADJP present)))))
      ,
      (S (S (NP  different (ADJP autonomic-somatic)
		 patterns)
	    (VP underlie
		(NP (NP (NP aggression) and (NP anxiety))
		    ,
		    (ADVP respectively)
		    ,)))
	 (PP as
	     (S  (NP *)  
		 (VP indicated
		     (PP by
			 (NP (NP the rate
				 (PP of
				     (NP the excretion
					 (PP of
					     (NP the catecholamines)))))
			     ,
			     (NP the state
				 (PP of
				     (NP the muscle tone)))
			     ,
			     and
			     (NP the Mecholyl test))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP The psychological incompatibility
       (PP of
	   (NP these emotional states)))
   (VP seems
       (S (NP *)
	  (AUX to)
	  (VP be
	      (VP (VP reflected
		      (PP in
			  (NP-7 *pseudo-attach*)))
		  ,
		  or
		  (VP based
		      (PP on
			  (NP-7 *pseudo-attach*)))
		  ,
		  (NP-7 this (ADJP marked) difference))))))
  .)
(  END_OF_TEXT_UNIT)
(  (NP (NP 15 .)
       (NP (VP Concluding)
	   remarks)))
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
((S  
  (PP In
      (NP our attempt
	  (S (NP *)
	     (AUX to)
	     (VP interpret
		 (NP the emotions)
		 (PP in
		     (NP their (ADJP physiological and pathological) range))))))
  ,
  (S (NP we)
     (VP emphasized
	 (NP the importance
	     (PP of
		 (NP (NP the degree
			 (PP of
			     (NP activity))
			 (PP of
			     (NP the (ADJP parasympathetic and sympathetic) divisions
				 (PP of
				     (NP the hypothalamic system)))))
		     and
		     (NP their influence
			 (PP on
			     (NP  (NP the (ADJP inhibitory and excitatory) systems)
				  ,
				  (ADVP respectively))))))))))
 .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S
   (NP We)
   (VP stressed
       (NP the reciprocal relation
	   (PP of
	       (NP these systems))
	   (PP (PP with
		   (NP respect
		       (PP to
			   (NP the
			       (ADJP autonomic-somatic) downward
			       discharge))))
	       (PP  (ADVP as
			  well)
		    as
		    (S (NP *) 
		       (VP regarding
			   (NP the (ADJP hypothalamic-cortical) discharge))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (SBAR Although
	   (S (NP we)
	      (VP are
		  (ADVP still)
		  (ADJP  far
			 (PP from
			     (NP a complete understanding
				 (PP of
				     (NP these problems))))))))
     ,
     (PP as
	 (NP a first approximation))
     ,
     (S (NP it)
	(AUX is)
	(VP suggested
	    (SBAR that
		  (S (NP alterations
			 (PP in
			     (NP the hypothalamic balance))
			 (PP with
			     (NP consequent changes
				 (PP in
				     (NP the (ADJP hypothalamic-cortical) discharges)))))
		     (VP account
			 (PP for
			     (NP (NP major changes
				     (PP in
					 (NP behavior)))
				 (VP seen
        
				     (PP in
					 (NP various moods and states
					     of
					     emotions
					     (PP in
						 (NP (NP man) and (NP beast)))))
				     (PP (PP under
					     (NP physiological circumstances))
					 ,
					 (PP in
					     (NP (ADJP experimental and clinical) neurosis))
					 ,
					 and
					 (PP as
					     (NP the result
						 (PP of
						     (NP psychopharmacological agents))))))))))))))
  .)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
( (S (PP In
	 (NP view
	     (PP of
		 (NP (NP (NP the important role)
			 (SBAR (WHNP which)
			       (S  
				(NP emotional disturbances)
				(VP play
				    (NP T)
				    (PP in
					(NP the genesis
					    (PP of
						(NP (ADJP neurotic and psychotic) disorders))))))))
		     and
		     (NP the parallelism
			 (VP observed
			     (PP between
				 (NP (NP autonomic states)
				     and
				     (NP psychological behavior)))
			     (PP in
				 (NP several instances))))))))
     ,
     (S (NP it)
	(AUX is)
	(ADVP further)
	(VP suggested
	    (SBAR that
		  (S (NP a hypothalamic imbalance)
		     (AUX may)
		     (VP play
			 (NP an important role)
			 (PP in
			     (S  (NP *) 
				 (VP initiating
				     (NP mental changes))))))))))
  .) 
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
(  END_OF_TEXT_UNIT)
